Table 8.
Multivariate regression results for long-term outcomes.
| Long-term outcome | Antiglycemic treatment model concordance rate | Antihypertensive treatment model concordance rate | Lipid-lowering treatment model concordance rate | Risk score (%) | ||||||
|
|
Coefficient (β) | P value | Coefficient (β) | P value | Coefficient (β) | P value | Coefficient (β) | P value | ||
| Myocardial infarction | –1.1150 | <.001 | –.8018 | <.001 | –1.0065 | <.001 | .0998 | <.001 | ||
| Heart failure | –.6294 | .04 | –1.4414 | <.001 | –1.0416 | <.001 | .0653 | <.001 | ||
| Stroke | –.3288 | .24 | –.4871 | .06 | –1.1715 | <.001 | .1210 | <.001 | ||
| Nephropathy | –.5667 | <.001 | –1.2648 | <.001 | –.5182 | <.001 | .0072 | <.001 | ||
| Other Microvascular | –.5382 | .001 | –.3956 | .004 | –.6296 | <.001 | .0552 | <.001 | ||
| Death | –.4922 | .02 | –.8872 | <.001 | –.9835 | <.001 | .0527 | <.001 | ||